Hemodynamic monitoring company Lidco said Tuesday Tim Hall would take up the role as Chief Financial Officer and Company Secretary from 11 March 2019.
Mr Hall was CFO of Oxford Gene Technology from 2012 until shortly after its recent acquisition by Sysmex Corporation. Prior to this, He was Finance Director at AIM-listed Lombard Medical Technologies PLC for six years and previously had senior finance roles in UCB S.A, Celltech Group plc and Medeva PLC.
Mr Hall would succeed Jill McGregor who, as previously announced, leaves Lidco on 22 March 2019, the company said.
At 10:06am: (LON:LID) LiDCO Group PLC share price was +0.1p at 3.5p